Education
About Us
Working with TipRanks
Follow Us
Graft Polymer (UK) PLC (GB:SVNS)
LSE:SVNS
RESEARCH TOOLSreports
SVNS Stock Chart & Stats
Day’s Range― - ―
52-Week Range0.10p - 1.41p
Previous CloseN/A
VolumeN/A
Average Volume (3M)9.49M
Market Cap
£2.76M
Enterprise Value765.32K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-1.29
Next Earnings
Sep 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding2,295,930,700
10 Day Avg. Volume4,540,904
30 Day Avg. Volume9,493,541
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)11.58
Price to Cash Flow (P/CF)-4.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Graft Polymer (UK) PLC News
PremiumCompany Announcements
Solvonis Therapeutics Rebrands and Refocuses on Mental Health
PremiumCompany Announcements
Solvonis Therapeutics Announces Proposed Acquisition of Awakn Life SciencesPremiumCompany Announcements
Solvonis Therapeutics Sees Change in Major Holdings
PremiumCompany Announcements
Solvonis Engages PharmaVentures for AUD Treatment Commercialisation
PremiumCompany Announcements
Solvonis Advances AWKN-SDN-14 PTSD Treatment ProgramPremiumCompany Announcements
Solvonis Therapeutics Announces Change in Major Holdings---
Options Prices
Currently, No data available
---
Ownership Overview
9.12% Insiders
―
Mutual Funds
― Other Institutional Investors
90.88% Public Companies and
Individual Investors
SVNS FAQ
What was Graft Polymer (UK) PLC’s price range in the past 12 months?
Graft Polymer (UK) PLC lowest share price was 0.10p and its highest was 1.41p in the past 12 months.
What is Graft Polymer (UK) PLC’s market cap?
Graft Polymer (UK) PLC’s market cap is £2.76M.
When is Graft Polymer (UK) PLC’s upcoming earnings report date?
Graft Polymer (UK) PLC’s upcoming earnings report date is Sep 25, 2025 which is in 154 days.
How were Graft Polymer (UK) PLC’s earnings last quarter?
Currently, no data Available
Is Graft Polymer (UK) PLC overvalued?
According to Wall Street analysts Graft Polymer (UK) PLC’s price is currently Overvalued.
Does Graft Polymer (UK) PLC pay dividends?
Graft Polymer (UK) PLC does not currently pay dividends.
What is Graft Polymer (UK) PLC’s EPS estimate?
Graft Polymer (UK) PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Graft Polymer (UK) PLC have?
Graft Polymer (UK) PLC has 2,295,930,700 shares outstanding.
What happened to Graft Polymer (UK) PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Graft Polymer (UK) PLC?
Currently, no hedge funds are holding shares in GB:SVNS
---
Company Description
Graft Polymer (UK) PLC
Graft Polymer (UK) PLC focuses on the development of polymer modification and drug delivery systems. It has licensed its Drug Delivery System platform IP to MGC Pharmaceuticals in relation to MGC Pharma's CimetrA product. The group's products address customer needs across a wide range of end use markets, from automotive through to medical and are not dependent on one market segment.
---
Technical Analysis
---